Case of soluble fms‐like tyrosine kinase 1 apheresis in severe pre‐eclampsia developed at 15 weeks’ gestation

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 1341-8076, Iss. 10, 2015-10 ,pp. : 1661-1663

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of small‐for‐gestational‐age neonates: screening by placental growth factor and soluble fms‐like tyrosine kinase‐1 at 35–37 weeks

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 46, Iss. 2, 2015-08 ,pp. : 191-197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum soluble fms‐like tyrosine kinase‐1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 584-590

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of genistein sFLT1 VEGF

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 2, 2015-02 ,pp. : 277-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased Serum Levels of Anti-Angiogenic Factors Soluble fms-Like Tyrosine Kinase and Soluble Endoglin in Sickle Cell Disease

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-11 ,pp. : 130-133

Karger

Access to resources Recommend Favorite